Bristol-Myers Squibb sell Barclays PLC
Start price
22.08.24
/
50%
€42.92
Target price
22.08.25
€37.80
Performance (%)
-4.19%
End price
23.08.25
€41.12
Summary
This prediction ended on 23.08.25 with a price of €41.12. With a performance of -4.19%, the SELL prediction for Bristol-Myers Squibb by Barclays_PLC was down slightly. Barclays_PLC has a follow-up prediction for Bristol-Myers Squibb, but this time predicts that Bristol-Myers Squibb is a Buy. A total of €1.15 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -5.231% | -5.231% | -1.612% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by Barclays_PLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Barclays PLC from $41.00 to $42.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€50.83
21.02.26
21.02.26
€63.65
21.02.27
21.02.27
-2.13%
07.04.26
07.04.26
Stopped prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€48.85
07.10.24
07.10.24
€39.19
07.10.25
07.10.25
-20.99%
08.10.25
08.10.25